Skip to main content

INSMED Inc

For the period ended Dec 31, 2023. Filed Feb 22, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 22, 2024

INSM$116.10+1.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

INDEX

PAGE
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS4
PART I6
ITEM 1BUSINESS6
ITEM 1ARISK FACTORS34
ITEM 1BUNRESOLVED STAFF COMMENTS61
ITEM 1CCYBERSECURITY61
ITEM 2PROPERTIES62
ITEM 3LEGAL PROCEEDINGS62
ITEM 4MINE SAFETY DISCLOSURES62
PART II63
ITEM 5MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES63
ITEM 6[RESERVED]65
ITEM 7MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS66
ITEM 7AQUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK75
ITEM 8FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA75
ITEM 9CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE75
ITEM 9ACONTROLS AND PROCEDURES75
ITEM 9BOTHER INFORMATION76
ITEM 9CDISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS76
PART III77
ITEM 10DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE77
ITEM 11EXECUTIVE COMPENSATION77
ITEM 12SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS77
ITEM 13CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE77
ITEM 14PRINCIPAL ACCOUNTANT FEES AND SERVICES77
PART IV78
ITEM 15EXHIBITS AND FINANCIAL STATEMENT SCHEDULES78
REPORTS OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM84
CONSOLIDATED FINANCIAL STATEMENTS87

Unless the context otherwise indicates, references in this Annual Report on Form 10-K to “Insmed Incorporated” refer to Insmed Incorporated, a Virginia corporation, and the “Company,” “Insmed,” “we,” “us” and “our” refer to Insmed Incorporated together with its consolidated subsidiaries. INSMED, PULMOVANCE, ARIKARES and ARIKAYCE are trademarks of Insmed Incorporated. This Annual Report on Form 10-K also contains trademarks of third parties. Each trademark of another company appearing in this Annual Report on Form 10-K is the property of its owner.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.